AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.

AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.

COLONIE It's easy to think of arthritis as a relatively minor set of aches and pains when you're young and healthy. Unfortunately, the reality is quite a bit harsher; there are over 100 vastly different types of this crippling disease that can affect the body in many different ways.

AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.

AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.